Advanced Oncotherapy, an Aim-listed healthcare company developing new therapies for treating cancer, has recruited a former Lehman Brothers banker – reuniting him with a former colleague at the US bank.

The company has appointed Nicolas Serandour as global head of finance, effective September 1, according to a statement this morning. The company, which has a market capitalisation of around £32 million, is developing particle treatment that is less toxic for cancer patients than conventional X-ray radiation.